You are here

News

2026

NEXT Biosciences: Treating Autism with Autologous UC-MSC
Sep 2026   In South Africa, a boy with autism who was previously nonverbal is now a chatterbox. He was the first patient in a program where children receive intrathecal injections of MSCs grown from their own cryopreserved umbilical cord tissue. 
Implementing Cord Blood Therapy for Cerebral Palsy in the US
Sep 2026   Clinicians who work with children that have cerebral palsy have identified five theme topics that impact the ability to implement cord blood therapy in more hospitals.
From Bank to Bedside: ReeLabs of India
Aug 2026   ReeLabs of India stores stem cells from six perinatal sources and four adult sources. ReeLabs is also at the forefront of the regenerative medicine revolution in India. They run clinical trials of cell therapies and offer a patented anti-aging treatment.
Delivering the Placenta
Aug 2026   The placenta is destined to be a temporary organ: when its time is up, a cascade of signals tells the mother's body to expel the placenta after birth. Safe delivery of the placenta is essential to prevent excessive bleeding after birth.
AABB 2026 Annual Meeting Registration
Jul 2026   Registration is now open for the AABB 2026 Annual Meeting, to be held Oct. 17-19 in Atlanta, Georgia, USA.
Red Blood Cells for Premature Babies as a product from Cord Blood Banks
Jul 2026   Extremely premature babies require multiple blood transfusions for anemia. But they benefit more from cord blood than adult blood, because it is rich in fetal hemoglobin. This need could be met by processing the red blood cells that cord blood banks routinely discard, turning it into a product for the transfusion of premature babies.
Neonatal cardiac transfusion as a product from cord blood banks
Jul 2026   Neonatal cardiac surgery is one of the largest and most predictable clinical settings in which autologous cord blood can already be incorporated into routine care. When this indication is included, the odds of using cord blood nearly double. Family cord blood banks should make more effort to tell this story and provide this service.
Interview with Rocio Ayala Edgerton of NECC
Jul 2026   Interview with Rocio Ayala Edgerton of New England Cryogenic Center, about their partnership with Kindbody.  
Interview with Nina Horowitz of ImmuneBridge
Jun 2026   We interview Nina Horowitz, PhD, the CEO of ImmuneBridge. Their technology can expand stem cells 100K-fold, making the large scale production of immunotherapy at affordable prices a possibility. They consider donated cord blood to be the ideal starting material for immunotherapy. 
Update on Pediatric Cord Blood Transplants in China
Jun 2026   China uses cord blood for about 500 pediatric stem cell transplants per year. This is more than Europe or North America.